Research programme: peptide therapeutics - Perspective Therapeutics
Alternative Names: peptide therapeutics - Perspective TherapeuticsLatest Information Update: 09 Feb 2024
At a glance
- Originator Perspective Therapeutics
- Class Antineoplastics; Peptides
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Solid tumours
Most Recent Events
- 31 Dec 2023 Early research in Solid tumours in USA (unspecified route), prior to December 2023 (Perspective Therapeutics pipeline, December 2023)